IceCure Medical (ICCM) Accumulated Expenses (2020 - 2026)

IceCure Medical (ICCM) has reported Accumulated Expenses for 7 consecutive years, with $3.2 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Accumulated Expenses fell 23.54% year-over-year to $3.2 million in Q2 2026; TTM through Jun 2026 was $3.2 million, a 23.54% decrease from a year earlier, with the FY2025 full-year figure at $2.7 million, down 3.55% from the prior year.
• Accumulated Expenses was $3.2 million for Q2 2026 at IceCure Medical, up from $2.9 million in the prior quarter.
• Over five years, Accumulated Expenses peaked at $4.2 million in Q2 2025 and troughed at -$141000.0 in Q4 2023.
• A 5-year average of $2.2 million and a median of $2.7 million in 2024 frame the typical range for Accumulated Expenses.
• Across the five-year window, Accumulated Expenses slumped 108.92% in 2023 and soared 2253.66% in 2026, its largest moves.
• Over 5 years, Accumulated Expenses stood at $1.6 million in 2022, then tumbled by 108.92% to -$141000.0 in 2023, then soared by 2055.32% to $2.8 million in 2024, then retreated by 3.55% to $2.7 million in 2025, then rose by 19.82% to $3.2 million in 2026.
• The last three Accumulated Expenses figures came in at $3.2 million (Q2 2026), $2.9 million (Q1 2026), and $2.7 million (Q4 2025), per Business Quant data.